Significantly, the simultaneous loss of dystrophin and dysferlin (Schmidt et al, 2011; Hosur et al, 2012) or dystrophin and calpain-3 (Schmidt et al, 2011) leads to a drastically increased sarcoma propensity, which is compatible with an additive TS function of these MD-related proteins. Here, DMD is linked to sarcoma.